QFA
Quattro Financial Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,000
| Closed | -$1.22M | – | 78 |
|
|
2024
Q2 | $1.22M | Hold |
5,000
| – | – | 0.32% | 45 |
|
|
2024
Q1 | $747K | Buy |
5,000
+4,809
| +2,518% | +$719K | 0.21% | 51 |
|
|
2023
Q4 | $957K | Sell |
191
-4,809
| -96% | -$24.1M | 0.33% | 46 |
|
|
2023
Q3 | $886K | Hold |
5,000
| – | – | 0.39% | 48 |
|
|
2023
Q2 | $950K | Hold |
5,000
| – | – | 0.38% | 46 |
|
|
2023
Q1 | $1M | Hold |
5,000
| – | – | 0.41% | 42 |
|
|
2022
Q4 | $1.19M | Buy |
+5,000
| New | +$1.19M | 0.47% | 34 |
|